ABOUT AUTOMATED SYSTEMS OF TACOMA
Since 1965, AST has been delivering innovative solutions – many of which were industry firsts and have since become industry standards. AST has always understood that our customers serve demanding and oftentimes unpredictable markets. We also understand that “flexibility is the antidote to uncertainty,” and as your partner, AST consistently seeks to deliver innovative solutions that are robust, yet flexible. AST is a technology leader specializing in advanced aseptic filling and closing systems. Our focus is to provide innovative and flexible products that satisfy the most challenging product and regulatory requirements for the Pharmaceutical and Biotechnology industries. AST’s spectrum of products includes semi-automated to completely automated and integrated cGMP manufacturing systems for processing vials, syringes and cartridges. To discover more about our products please select a product category.
CDMO Quality Chemical Laboratories Purchases Two Filling Systems From AST To Increase Capacity
Automated Systems of Tacoma, LLC (AST), a leading provider of flexible aseptic filling systems, and Quality Chemical Laboratories, LLC (QCL), a Contract Development and Manufacturing Organization (CDMO) announce their partnership on two multi-format filling and closing machines for use in cGMP aseptic small batch processing.
Overcome The Challenges Of Small Batch Production While Maximizing Yield
A minimal amount of available API poses major challenges when filling a product, making process efficiency a critical factor in reducing waste and improving the yield for small batches of drug product.
Improve Sterility Assurance And Data Integrity In A 503B Compounding Pharmacy
Implementing automated technologies and robotics could be the solution 503B compounding pharmacies need to overcome growing issues with sterility and data integrity.
AST And Goodwin Biotechnology Partner On A GENiSYS® C20 Aseptic Small Batch Filling & Closing Machine
Automated Systems of Tacoma, LLC (AST), a leading provider of flexible aseptic filling systems, and Goodwin Biotechnology, Inc. (Goodwin), a Contract Development and Manufacturing Organization (CDMO) announce their partnership on a GENiSYS C20 multi-format filling and closing machine for syringes, cartridges and vials.
The Advantages Of Robotics In Aseptic Fill Finish
As you move into a future of diverse pipelines that present both great opportunities and challenges, consider utilizing a flexible solution like robotics that can be rapidly implemented into your facility.
How Robotics Offer New Answers To Today's Challenges In Pharma
We are proud to announce that AST president and CEO Joe Hoff will be a panelist in the upcoming webinar "Pharmaceutical industry: How robotics offer new answers to today's challenges," hosted by Staubli.
Bridging The Divide - Streamline The Process Development & Tech Transfer Process
Preparing drug products for tech transfer can be a daunting task. Traditional process development practices tend to be labor intensive, difficult to scale to a manufacturing environment, and gathering the critical process data to make informed decisions can be a challenge. This article describes how the advantages of AST's GENiSYS® system can streamline the tech transfer process by enabling efficient drug development activities and process data collection.
February 26 Webinar: Bringing Flexibility And Precision To Fill Injectables Using Robots
The upcoming 30-minute webinar presents an overview of the company’s mission and values, along with a detailed product overview highlighting how AST’s machines respond to the unique challenges found across a variety of filling applications.
Delivering Flexibility Without Complexity
Next generation drug products are more targeted and patient specific by nature causing batch sizes to be much smaller. This paradigm shift paves the way for more flexible manufacturing solutions.
Robotics, Isolators & Restricted Access Barrier Systems (RABS)
The aim of advanced aseptic processing is the elimination and absolute control of all sources of contaminations - most importantly, human generated contamination. Robotics and isolator-barrier systems will be the core technologies in meeting this endeavor.
ASEPTiCell® Robotic Filling And Finishing
AST’s ASEPTiCell® provides flexible, robotic filling and finishing of vials, syringes and cartridges for small to medium clinical and commercial batches. AST’s modular design allows the ASEPTiCell to be built to your specification without the cost and risk of customization.
GENiSYS® R Robotic Handling
The GENiSYS® R offers a unique blend of automated capabilities to ensure your sterile products are processed in strict accordance with cGMP requirements. With robotic handling available from bag opening to vial sealing, and integration with barrier technologies, your product is protected from contamination through all stages of processing.
Maximize Productivity With The GENiSYS® R
GENiSYS® R provides ultimate flexibility for processing ready-to-use vials, syringes and cartridges on a single machine. Highly reliable robotics and recipe driven changeovers allow for complete format changes in as little as 30 minutes. Maximize productivity and return-on-investment with the GENiSYS R.
GENiSYS® Lab Semi-Automatic Systems
AST’s GENiSYS® Lab semi-automatic systems are ideal for drug product development and cGMP production applications. Each system automates the critical aseptic operations for vial, syringe and cartridge processing to reduce contamination risk and product variability. GENiSYS Lab offers a perfect balance between automated features, size and affordability without compromising quality, safety and ease of use.
How Robotics Offer Answers To Today’s Pharmaceutical Manufacturing Challenges
What are the COVID-19 effects on pharmaceutical manufacturing? Can we expect “onshoring” strategies following the crisis? Is the general opinion about robotics improving? Watch this webinar to learn more about where and how robotics add value and solve problems.